Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

C'mon folks: Think back for a minute. B initial trial was against bacteria. Why did they choose cellulitis for the trial? Because B is great against Staph and Strep. Very high MIC. Those are skin bugs. They are not UTI or GI. Why choose cellulitis for the first trial? Because that is where b is at its very best- in the world of bacteria.

It is not so great against other bugs. Take Pseudomonas. MIC NOT GOOD enough to lead to an initial trial for GI or GU use. NOT GOOD ENOUGH.

Killing a bug does not count at all in the world of medicine and drug development and approval. How well you kill it is critical. The be all and the end all.

If you do not get this you should not invest in biotech.